NeuroSense Therapeutics Stock (NASDAQ: NRSN) stock price, news, charts, stock research, profile.
You can purchase shares of NeuroSense Therapeutics (NASDAQ:NRSN) through any online brokerage.
There are no as such competitors for NeuroSense Therapeutics.
NeuroSense Therapeutics has a consensus price target of $7.25.
The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $1.35 last updated November 11, 2024 at 9:27 AM EST.
There are no upcoming dividends for NeuroSense Therapeutics.
NeuroSense Therapeutics’s Q3 earnings are confirmed for Tuesday, November 26, 2024.
There is no upcoming split for NeuroSense Therapeutics.
NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.